1.
Xu W. CRISPR/Cas9-Mediated PD-1 Engineered T Cells: New Strategy to Block Tumor Immune Escape. IJBLS [Internet]. 2026 Aug. 24 [cited 2026 Nov. 22];16(1):252-5. Available from: https://drpress.org/ojs/index.php/ijbls/article/view/35702